Search results for: 'qualitative dxp analysis research'

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

18 Aug 2025  |  Global  |  Market Research

Cell Biology Research Market, Global, 2024–2030

Cell Biology Research is Experiencing Transformational Growth due to Advances in Single-Cell Technologies and Genomics Tools

Infographics

×

In the study, Frost & Sullivan examines the global cell biology research market. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones. This growth reflects accelerating innovation across instrumentation, consumables, and software platforms, with a firm push from data-driven research models, ...

This Frost Radar™ benchmarks leading digital experience platform (DXP) vendors as the platforms consolidate from fragmented experience stacks into unified orchestration layers that integrate content management, customer data, agentic AI, and multichannel delivery in a single operating environment. Governance has emerged as a primary competitive dif...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

The Frost Radar for the digital experience platform (DXP) market analyzes providers offering software solutions that allow organizations to plan, distribute, manage, measure, and optimize omnichannel customer interactions through a set of tools. It plots 12 selected providers based on 10 growth and innovation criteria comprising quantitative and q...

The Frost & Sullivan Q1 2011 Vulnerability Tracker is compiled from various public sources to analyze the vulnerability landscape from 2000 to the present. Vulnerability data is collected, queried, and segmented, resulting in a wealth of information that is intended to provide qualitative commentary on the research industry and to recognize the mos...

The Frost & Sullivan Q2 2011 Vulnerability Tracker is compiled from various public sources to analyze the vulnerability landscape from 2000 to the present. Vulnerability data is collected, queried, and segmented, resulting in a wealth of information that is intended to provide qualitative commentary on the research industry and to recognize the mos...